American pharmaceutical giant Pfizer on Wednesday informs the Central government that its COVID-19 vaccine is suitable for all aged 12 and above and can be stored at 2-8 degrees for over a month, according to the sources.
They (Pfizer and the Indian government) also discussed the indemnity protection against liabilities and asked for relaxations in some clauses before the company brings its COVID-19 vaccines to India, the sources added.
The drug-maker is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday.
Meanwhile, Moderna, another pharmaceutical giant in the US, sources said, is expecting to start manufacturing its COVID-19 vaccines in India following analysis with Cipla, a pharmaceutical company based in Mumbai, among other Indian firms.
Earlier, both drug-makers had allegedly refused to send vaccines directly to the state governments of Delhi and Punjab, claiming that they will only deal with the Central government.
Surjitt Sahani
